| Confirmed minutes
of
14th
October 2004
PRESCRIPTION PRICING
AUTHORITY
Minutes of the public
meeting held on Thursday 14 October 2004 in the Board
Room, Bridge House, Newcastle upon Tyne.
PRESENT
| Chairman: |
Mrs A Galbraith |
| |
|
| Non-Executive
Members: |
Dr M Ali
Mr M Bennett
Mr K Murphy
Mr J Norman
Dr S Purdy
Mr N Scholte
Dr J Stockwell |
IN ATTENDANCE
|
Directors: |
Mr D Ball
Mrs C Dalton
Mr M King
Mr A McDonald
Mr M Siswick
Mr J Smith |
| |
|
| Secretariat:
|
Miss
C Hailes |
| |
|
1
CHAIRMAN'S INTRODUCTIONS
The
Chairman indicated that members of the public were welcome
and outlined the format of the meeting. The PPA is required
to hold a public meeting each year to present its Annual
Report by the end of October. On this occasion the Annual
Report would be presented as part of the normal monthly
agenda and members of the public were welcome to stay
and observe the remainder of the meeting.
2 ANNUAL REPORT 2002-2003
AND PRESENTATION
Mr
King presented the Annual Report and identified the
key areas of performance during 2003-2004.
An
overview was presented that described our key activities
in respect of:
- pricing
prescriptions and remuneration to contractors
-
prescribing and dispensing information services
-
the Drug Tariff
-
provision of analysis and advice
-
patient services and help with health costs
In
particular Mr King referred to our contribution to national
NHS developments by providing services, advice and support.
He also highlighted internal developments such as:
-
the Capacity Improvement Programme
- moving
from paper to electronic information
-
the expansion of the range of patient services and
improved awareness and access
-
developing our range of managed services
In
conclusion, a summary of our financial performance was
provided against a wider portfolio of activities that
had remained within budget.
The
Chairman welcomed the summary presented by Mr King which
was a good reminder of all the achievements and successes
throughout the year often under stringent timeframes
and difficult circumstances. Members echoed the comments
of the Chairman.
3 APOLOGIES FOR ABSENCE
There were no apologies for absence.
4 MINUTES OF THE PREVIOUS MEETING HELD ON 9 SEPTEMBER
2004
The
minutes of the previous meeting held on 9 September
2004 were received and confirmed as a correct record.
5 MATTERS ARISING FROM PREVIOUS MEETING
There
were no matters arising from the previous meeting.
6 KEY PERFORMANCE INDICATORS
Mr
King presented two months data relating to the key performance
indicators. He noted that the cumulative target in respect
of prescription pre-payment certificates was stretching
but that it had nearly been achieved for the month of
August 2004.
Mr
McDonald clarified that the planned expenditure on recruitment
would not significantly increase the data capture cost
per thousand.
7 UPDATE ON GROWTH IN PRESCRIPTION
VOLUME AND COST YEAR TO JUNE 2004
Mrs
Dalton summarised the above report and highlighted the
main trends and the factors affecting growth in volume
and cost of prescriptions and the complexity of prescription
processing. An analysis had shown that for the year
to June 2004 prescription volume had increased by 5.8%
and that the cost has increased by 8.6%.
In
September 2003 the Department of Health (DH) issued
a consultation document about the arrangements for the
future supply and reimbursement of generic medicines
for the NHS that, if implemented, will replace the Maximum
Price Scheme for generic medicines. Subsequently, in
December 2003, proposals to reduce the reimbursement
price of four generic medicines were implemented and
further reductions for the same four generics were implemented
in September 2004. Those reductions will enable to DH
to secure savings of £150 million. As a result
of that decision the volume of items for all of the
four generic drugs has increased by over 800,000 for
6 months to June 2004 compared to the previous 6 months.
Dr Purdy identified the connection between the reduction
in price of the drugs and the impact on prescription
volume and complexity. It was not felt that this was
easily identifiable in the report and it was AGREED
that the paper would be amended to highlight this fact
prior to publication.
Mr
Murphy welcomed the report that if available to PCTs
would stimulate debate especially in relation to the
current initiative on Practice Based Commissioning.
Mrs Dalton confirmed that an annual report on growth
in prescription volume and cost is published and available
at exhibitions and a periodic update is published on
the PPA web site.
8 STAKEHOLDER RELATIONS
Mr
King presented an update on the activities with stakeholders
in the previous 6 months. In particular attendance at
the Primary Care 2004 and the NHS Confederation Conference
had generated a lot of interest in the Electronic Drug
Tariff.
The
Stakeholder Forums had concentrated on the promotion
of "Help with Health Costs". Active participants
in those forums are the Patient Advice and Liaison Services
(PALS) representatives and as a result additional links
have been developed.
9 PEOPLE ISSUES
MMr
Siswick outlined the HR activities that were progressing
across the organisation to support operational initiatives
and the delivery of business objectives. In particular
he highlighted the
- review
of training
-
activities of the Race Relations Standing Committee
and the National Equality and Diversity groups
-
HR policy review
and
the work associated with the development of managed
services.
Dr
Stockwell enquired whether there was a requirement to
recruit additional HR and Finance staff to support the
additional activities associated with managed services.
Mr Siswick confirmed that there is a service level agreement
with defined levels of service and that quarterly reviews
are held with the organisations to review the level
of service. However, each organisation requires different
levels of service which is being managed within current
establishment. If managed services continue to develop
then staffing levels would need to be considered.
Following
a review of the management information relating to Ethnic
Groups at Appendix G it was requested and AGREED that
information would be provided at the next meeting that
showed a comparison over the proceeding two years and
provides a comparative against the local community.
10 STAFF OPINION SURVEY
Members
reviewed the outcome of the 2003 Staff Opinion Survey
and were pleased with the 48% response rate which was
above the national average. However, although that figure
was below previous response rates it was seen as positive
indicating that staff were mainly content and did not
have issues to raise. Mr Siswick advised that a special
edition of PPA People incorporating action plans was
shortly to be published.
11
VERBAL UPDATE FROM AUDIT COMMITTEE : 13 MAY 2004
Dr
Stockwell provided an update on discussion at the Audit
Committee that had included a:
- review
of the Internal Audit progress report
-
discussion on the draft External Audit management
letter that had included a review of the year end
position on the annual accounts
-
a review of the revised DH risk management process
Members
were also advised that the Audit Committee had carried
out a self assessment of their performance against DH
guidance and information provided by KPMG. A debate
had been held regarding the powers of the Audit Committee
to seek legal advice which was being clarified.
Dr
Stockwell also advised that the Audit Committee would
be reviewing their Terms of Reference at the next meeting
which would require endorsement by Members in February
2005.
12 FUTURE BUSINESS OF THE AUTHORITY
Members
noted the future business.
13 DATE OF NEXT/FUTURE MEETINGS OF
THE AUTHORITY
The
next meeting of the Authority would take place on Thursday
25 November 2004 at 10.30am in the Somerville Suite,
Maften Hall, Maften, Newcastle upon Tyne. That
meeting would be immediately followed by a session to
review the strategy of the organisation.
Future
meetings would be held as follows:
|